Pediatric chronic spontaneous urticaria: a brief clinician’s guide

References

• Zuberbier T, Abdul Latiff AH, Abuzakouk M, et al., The international EAACI/GA2LEN/EuroGuiDerm/APAAACI guideline for the definition, classification, diagnosis, and management of urticaria. Allergy. 77(3): 734–766. 2022.
   PubMed Web of Science ®Google Scholar
• Maurer M, Zuberbier T, Metz M. The classification, pathogenesis, diagnostic workup, and management of urticaria: an update. Handb Exp Pharmacol. 2022;268:117–133.
   PubMedGoogle Scholar
• Talarico V, Marseglia GL, Lanari M, et al. Pediatric urticaria in the emergency department: epidemiological characteristics and predictive factors for its persistence in children. Eur Ann Allergy Clin Immunol. 2021;53(2):80–85.
   PubMedGoogle Scholar
• Fricke J, Ávila G, Keller T, et al. Prevalence of chronic urticaria in children and adults across the globe: systematic review with meta-analysis. Allergy. 2020;75(2):423–432.
   PubMed Web of Science ®Google Scholar
• Hiragun M, Hiragun T, Mihara S, et al. Prognosis of chronic spontaneous urticaria in 117 patients not controlled by a standard dose of antihistamine. Allergy. 2013;68(2):229–235.
   PubMed Web of Science ®Google Scholar
• Maurer M, Eyerich K, Eyerich S, et al. Urticaria: collegium internationale allergologicum (CIA) update 2020. Int Arch Allergy Immunol. 2020;181(5):321–333.
   PubMed Web of Science ®Google Scholar
• Sussman G, Abuzakouk M, Bérard F, et al. Angioedema in chronic spontaneous urticaria is underdiagnosed and has a substantial impact: analyses from ASSURE-CSU. Allergy. 2018;73(8):1724–1734.
   PubMed Web of Science ®Google Scholar
• Gonçalo M, Gimenéz-Arnau A, Al-Ahmad M, et al. The global burden of chronic urticaria for the patient and society. Br J Dermatol. 2021;184(2):226–236.
   PubMed Web of Science ®Google Scholar
• Altrichter S, Zampeli V, Ellrich A, et al. IgM, and IgA in addition to IgG autoantibodies against FcɛRIα are frequent and associated with disease markers of chronic spontaneous urticaria. Allergy. 2020;75(12):3208–3215.
   PubMedGoogle Scholar
• Altrichter S, Fok JS, Jiao Q, et al. Total IgE as a marker for chronic spontaneous urticaria. Allergy Asthma Immunol Res. 2021;13(2):206–218.
   PubMedGoogle Scholar
• Kolkhir P, Church MK, Altrichter S, et al. Eosinopenia, in chronic spontaneous urticaria, is associated with high disease activity, autoimmunity, and poor response to treatment. J Allergy Clin Immunol Pract. 2020;8(1):318–325.
   PubMed Web of Science ®Google Scholar
• Davis MDP, van der Hilst JCH. Mimickers of urticaria: urticarial vasculitis and autoinflammatory diseases. J Allergy Clin Immunol Pract. 2018;6(4):1162–1170.
   PubMedGoogle Scholar
• Church MK, Weller K, Stock P, et al. Chronic spontaneous urticaria in children: itching for insight. Pediatr Allergy Immunol. 2011;22(1–Part–I):1–8.
   PubMedGoogle Scholar
• Zuberbier T, Aberer W, Asero R, et al. The EAACI/GA2LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria. Allergy. 2018;73(7):14–1393.
   Google Scholar
• Bernstein JA, Lang DM, and Khan DA, et al. The diagnosis and management of acute and chronic urticaria: 2014 update. J Allergy Clin Immunol. 2014;133(5):1270–1277.
   PubMedGoogle Scholar
• Wedi B, Raap U, Wieczorek D, et al. Urticaria and infections. Allergy Asthma Clin Immunol. 2009;5(1):10.
   PubMedGoogle Scholar
• Shakouri A, Compalati E, Lang DM, et al. Effectiveness of Helicobacter pylori eradication in chronic urticaria: evidence-based analysis using the grading of recommendations assessment, development, and evaluation system. Curr Opin Allergy Clin Immunol. 2010;10(4):362–369.
   PubMedGoogle Scholar
• Netchiporouk E, Sasseville D, Moreau L, et al. Evaluating comorbidities, natural history, and predictors of early resolution in a cohort of children with chronic urticaria. JAMA Dermatol. 2017;153(12):1236–1242.
   PubMed Web of Science ®Google Scholar
• Azkur D, Civelek E, Toyran M, et al. Clinical and etiologic evaluation of the children with chronic urticaria. Allergy Asthma Proc. 2016;37(6):450–457.
   PubMedGoogle Scholar
• Rudenko M. The role of infection and autoimmunity in urticaria and angioedema as common entity. EMJ Allergy Immunol. 2021;6:79–85.
   Google Scholar
• Kudryavtseva AV, Neskorodova KA, Staubach P. Urticaria in children and adolescents: an updated review of the pathogenesis and management. Pediatr Allergy Immunol. 2019;30(1):17–24.
   PubMed Web of Science ®Google Scholar
• Imbalzano E, Casciaro M, Quartuccio S, et al. Association between urticaria and virus infections: a systematic review. Allergy Asthma Proc. 2016;37(1):18–22.
   PubMedGoogle Scholar
• Dreyfus DH. Serological evidence that activation of ubiquitous human herpesvirus-6 (HHV-6) plays a role in chronic idiopathic/spontaneous urticaria (CIU). Clin Exp Immunol. 2016;183(2):230–238.
   PubMedGoogle Scholar
• Du Toit G, Prescott R, Lawrence P, et al. Autoantibodies to the high-affinity IgE receptor in children with chronic urticaria. Ann Allergy Asthma Immunol. 2006;96(2):341–344.
   PubMedGoogle Scholar
• Sahiner UM, Civelek E, Tuncer A, et al. Chronic urticaria: etiology and natural course in children. Int Arch Allergy Immunol. 2011;156(2):224–230.
   PubMedGoogle Scholar
• Chansakulporn S, Pongpreuksa S, Sangacharoenkit P, et al. The natural history of chronic urticaria in childhood: a prospective study. J Am Acad Dermatol. 2014;71(4):663–668.
   PubMedGoogle Scholar
• Eser I, Yologlu N, Baydemir C, et al. The predictive factors for remission of chronic spontaneous urticaria in childhood: outcome from a prospective study. Allergol Immunopathol (Madr). 2016;44(6):537–541.
   PubMedGoogle Scholar
• Arik Yilmaz E, Karaatmaca B, Cetinkaya PG, et al. The persistence of chronic spontaneous urticaria in childhood is associated with the urticaria activity score. Allergy Asthma Proc. 2017;38(2):136–142.
   PubMedGoogle Scholar
• Kowalski ML, Woessner K, Sanak M. Approaches to the diagnosis and management of patients with a history of nonsteroidal anti-inflammatory drug-related urticaria and angioedema. J Allergy Clin Immunol. 2015;136(2):245–251.
   PubMed Web of Science ®Google Scholar
• Mastrorilli C, Bernardini R, Liotti L, et al. Chronic urticaria and drug hypersensitivity in children. Acta Biomed. 2019;90(3–S):61–65.
   PubMedGoogle Scholar
• Caffarelli C, Paravati F, El Hachem M, et al. Management of chronic urticaria in children: a clinical guideline. Ital J Pediatr. 2019;45(1):101.
   PubMed Web of Science ®Google Scholar
• Metz M, Altrichter S, Buttgereit T, et al. The diagnostic work-up in chronic spontaneous urticaria-what to test and why. J Allergy Clin Immunol Pract. 2021;9(6):2274–2283.
   PubMedGoogle Scholar
• Votto M, Castagnoli R, De Filippo M, et al. Behavioral issues and quality of life in children with eosinophilic esophagitis. Minerva Pediatr. 2020;72(5):424–432.
   PubMedGoogle Scholar
• Licari A, Ciprandi R, Marseglia G, et al. Anxiety and depression in adolescents with severe asthma and in their parents: preliminary results after 1 year of treatment. Behav Sci (Basel). 2019;9(7):78.
   Google Scholar
• Fok JS, Kolkhir P, Church MK, et al., Predictors of treatment response in chronic spontaneous urticaria. Allergy. 76(10): 2965–2981. 2021.
   PubMed Web of Science ®Google Scholar
• Eckman JA, Hamilton RG, Gober LM, et al. Basophil phenotypes in chronic idiopathic urticaria in relation to disease activity and autoantibodies. J Invest Dermatol. 2008;128(8):1956–1963.
   PubMed Web of Science ®Google Scholar
• Cho CB, Stutes SA, Altrich ML, et al. Autoantibodies in chronic idiopathic urticaria and nonurticarial systemic autoimmune disorders. Ann Allergy Asthma Immunol. 2013;110(1):29–33.
   PubMedGoogle Scholar
• Marques RZ, Criado RF, Filho MCD, et al. Correlation between the histopathology of chronic urticaria and its clinical picture. An Bras Dermatol. 2016;91(6):760–763.
   PubMed Web of Science ®Google Scholar
• Shin B, Kwon HS, Park S, et al. Blood immunoglobulin E and eosinophil levels predict treatment response to omalizumab in refractory chronic urticaria. Allergy. 2013;68:36.
   Google Scholar
• Weller K, Zuberbier T, Maurer M. Clinically relevant outcome measures for assessing disease activity, disease control and quality of life impairment in patients with chronic spontaneous urticaria and recurrent angioedema. Curr Opin Allergy Clin Immunol. 2015;15(3):220–226.
   PubMed Web of Science ®Google Scholar
• Gabrielli S, Mulé P, Prosty C, et al. Validation of UAS7 among children with chronic spontaneous urticaria. J Allergy Clin Immunol Pract. 2022;10(7):1927–1929.e1.
   PubMedGoogle Scholar
• Ohanyan T, Schoepke N, Bolukbasi B, et al. Responsiveness and minimal important difference of the urticaria control test. J Allergy Clin Immunol. 2017;140(6):1710–1713.
   PubMed Web of Science ®Google Scholar
• Weller K, Donoso T, Magerl M, et al. Development of the angioedema control test-A patient-reported outcome measure that assesses disease control in patients with recurrent angioedema. Allergy. 2020;75(5):1165–1177.
   PubMedGoogle Scholar
• Weller K, Ardelean E, Scholz E, et al. Can on-demand non-sedating antihistamines improve urticaria symptoms? A double-blind, randomized, single-dose study. Acta Derm Venereol. 2013;93(2):168–174.
   PubMedGoogle Scholar
• Lewis-Jones MS, Finlay AY. The Children’s Dermatology Life Quality Index (CDLQI): initial validation and practical use. Br J Dermatol. 1995;132(6):942–949.
   PubMed Web of Science ®Google Scholar
• Holme SA, Man I, Sharpe JL, et al. The children’s dermatology life quality index: validation of the cartoon version. Br J Dermatol. 2003;148(2):285–290.
   PubMedGoogle Scholar
• Williams PV. Pharmacologic management of chronic urticaria in pediatric patients: the gap between guidelines and practice. Paediatr Drugs. 2020;22(1):21–28.
   PubMedGoogle Scholar
• Chang J, Cattelan L, Ben-Shoshan M, et al. Management of pediatric chronic spontaneous urticaria: a review of current evidence and guidelines. J Asthma Allergy. 2021;14:187–199.
   PubMed Web of Science ®Google Scholar
• Parisi GF, Leonardi S, Ciprandi G, et al. Cetirizine use in childhood: an update of a friendly 30-year drug. Clin Mol Allergy. 2020;18(1):2.
   PubMedGoogle Scholar
• Staevska M, Popov TA, Kralimarkova T, et al. The effectiveness of levocetirizine and desloratadine in up to 4 times conventional doses in difficult-to-treat urticaria. J Allergy Clin Immunol. 2010;125(3):676–682.
   PubMed Web of Science ®Google Scholar
• Parisi GF, Leonardi S, Ciprandi G, et al. Antihistamines in children and adolescents: a practical update. Allergol Immunopathol (Madr). 2020;48(6):753–762.
   PubMedGoogle Scholar
• Siebenhaar F, Degener F, Zuberbier T, et al. High-dose desloratadine decreases wheal volume and improves cold provocation thresholds compared with standard-dose treatment in patients with acquired cold urticaria: a randomized, placebo-controlled, crossover study. J Allergy Clin Immunol. 2009;123(3):672–679.
   PubMed Web of Science ®Google Scholar
• Cornillier H, Giraudeau B, Munck S, et al. Chronic spontaneous urticaria in children - a systematic review on interventions and comorbidities. Pediatr Allergy Immunol. 2018;29(3):303–310.
   PubMedGoogle Scholar
• Castagnoli R, De Filippo M, Votto M, et al. An update on biological therapies for pediatric allergic diseases. Minerva Pediatr. 2020;72(5):364–371.
   PubMed Web of Science ®Google Scholar
• Licari A, Manti S, Marseglia A, et al. Biologics in children with allergic diseases. Curr Pediatr Rev. 2020;16(2):140–147.
   PubMed Web of Science ®Google Scholar
• Ari A, Levy Y, Segal N, et al. Efficacy of omalizumab treatment for pediatric chronic spontaneous urticaria: a multicenter retrospective case series. Pediatr Dermatol. 2020;37(6):1051–1054.
   PubMedGoogle Scholar
• Votto M, De Filippo M, Licari A, et al. Biological therapies in children and adolescents with severe uncontrolled asthma: a practical review. Biologics. 2021;15:133–142.
   PubMed Web of Science ®Google Scholar
• De Filippo M, Votto M, Licari A, et al. Novel therapeutic approaches targeting endotypes of severe airway disease. Expert Rev Respir Med. 2021;15(10):1303–1316.
   PubMed Web of Science ®Google Scholar
• Agache I, Akdis CA, Akdis M, et al., EAACI biologicals guidelines-omalizumab for the treatment of chronic spontaneous urticaria in adults and in the paediatric population 12-17 years old. Allergy. 77(1): 17–38. 2022.
   PubMedGoogle Scholar
• Khan DA. Hypersensitivity and immunologic reactions to biologics: opportunities for the allergist. Ann Allergy Asthma Immunol. 2016;117(2):10–115.
   Google Scholar
• Alizadeh Aghdam M, van den Broek F, Rijken F, et al. High-dose omalizumab use in patients with chronic spontaneous urticaria. J Allergy Clin Immunol Pract. 2020;8(4):1426–1427.
   PubMedGoogle Scholar
• Dekkers C, Alizadeh Aghdam M, de Graaf M, et al. Safety and effectiveness of omalizumab for the treatment of chronic urticaria in pediatric patients. Pediatr Allergy Immunol. 2021;32(4):720–726.
   PubMedGoogle Scholar
• Maurer M, Metz M, Brehler R, et al. Omalizumab treatment in patients with chronic inducible urticaria: a systematic review of published evidence. J Allergy Clin Immunol. 2018;141(2):638–649.
   PubMed Web of Science ®Google Scholar
• Al-Shaikhly T, Rosenthal JA, Ayars AG, et al. Omalizumab for chronic urticaria in children younger than 12 years. Ann Allergy Asthma Immunol. 2019;123(2):208–210.
   PubMedGoogle Scholar
• Giménez-Arnau AM, Toubi E, Marsland AM, et al. Clinical management of urticaria using omalizumab: the first licensed biological therapy available for chronic spontaneous urticaria. J Eur Acad Dermatol Venereol. 2016;30:25–32.
   PubMed Web of Science ®Google Scholar
• Türk M, Maurer M, İ Y. How to discontinue omalizumab in chronic spontaneous urticaria? Allergy. 2019;74(4):821–824.
   PubMed Web of Science ®Google Scholar
• Maoz-Segal R, Levy T, Haj-Yahia S, et al. Combination therapy with omalizumab and an immune-suppressive agent for resistant chronic spontaneous urticaria - A real-life experience. World Allergy Organ J. 2020;13(8):100448.
   PubMed Web of Science ®Google Scholar
• Kolkhir P, Altrichter S, Munoz M, et al. New treatments for chronic urticaria. Ann Allergy Asthma Immunol. 2020;124(1):2–12.
   PubMed Web of Science ®Google Scholar
• Maurer M, Khan DA, Elieh Ali Komi D, et al. Biologics for the use in chronic spontaneous urticaria: when and which. J Allergy Clin Immunol Pract. 2021;9(3):1067–1078.
   PubMed Web of Science ®Google Scholar
• Chen JB, Ramadani F, Moy P, et al. Structural basis for selective inhibition of immunoglobulin E-receptor interactions by an anti-IgE antibody. Sci Rep. 2018;8(1):11548.
   PubMedGoogle Scholar
• Harris JM, Cabanski CR, Scheerens H, et al. A randomized trial of quilizumab in adults with refractory chronic spontaneous urticaria. J Allergy Clin Immunol. 2016;138(6):1730–1732.
   PubMed Web of Science ®Google Scholar
• Licari A, Castagnoli R, Marseglia A, et al. Dupilumab to treat type 2 inflammatory diseases in children and adolescents. Paediatr Drugs. 2020;22(3):10–295.
   Google Scholar
• Lee JK, Simpson RS. Dupilumab as a novel therapy for difficult to treat chronic spontaneous urticaria. J Allergy Clin Immunol Pract. 2019;7(5):1659–1661.
   PubMed Web of Science ®Google Scholar
• Magerl M, Terhorst D, Metz M, et al. Benefit of mepolizumab treatment in a patient with chronic spontaneous urticaria. J Dtsch Dermatol Ges. 2018;16(4):477–478.
   PubMed Web of Science ®Google Scholar
• Maurer M, Altrichter S, Metz M, et al. Benefit from reslizumab treatment in a patient with chronic spontaneous urticaria and cold urticaria. J Eur Acad Dermatol Venereol. 2018;32(3):e112–e3.
   PubMed Web of Science ®Google Scholar
• Bernstein JA, Singh U, Rao MB, et al. D. Treatment of chronic spontaneous urticaria with benralizumab: report of primary endpoint per-protocol analysis and exploratory endpoints. Allergy. 2021;76(4):1277–1280.
   PubMedGoogle Scholar
• Altrichter S, Staubach P, Pasha M, et al. An open-label, proof-of-concept study of lirentelimab for antihistamine-resistant chronic spontaneous and inducible urticaria. J Allergy Clin Immunol. 2021;149(5):S0091-6749(21)02682–8.
   Google Scholar
• Saini S, Shams M, Bernstein JA, et al. Urticaria and angioedema across the ages. J Allergy Clin Immunol Pract. 2020;8(6):1866–1874.
   PubMed Web of Science ®Google Scholar
• Wang EA, Chan SK. Chronic urticaria in children: an update on diagnosis and treatment. Curr Allergy Asthma Rep. 2020;20(8):31.
   PubMed Web of Science ®Google Scholar
• Hon KL, Li JTS, Leung AKC, et al. Current and emerging pharmacotherapy for chronic spontaneous urticaria: a focus on non-biological therapeutics. Expert Opin Pharmacother. 2021;22(4):497–509.
   PubMed Web of Science ®Google Scholar
• Tsabouri S, Arasi S, Beken B, et al. A European survey of management approaches in chronic urticaria in children: EAACI pediatric urticaria taskforce. Pediatr Allergy Immunol. 2022;33(1):e13674.
   PubMedGoogle Scholar
• Kocatürk E, Salman A, Cherrez-Ojeda I, et al. The global impact of the COVID-19 pandemic on the management and course of chronic urticaria. Allergy. 2021;76(3):816–830.
   PubMedGoogle Scholar
• De Filippo M, Votto M, Brambilla I, et al. Allergy and COVID-19. Acta Biomed. 2021;92(S7):e2021522.
   PubMedGoogle Scholar
• Cianferoni A, Votto M. COVID-19 and allergy: how to take care of allergic patients during a pandemic? Pediatr Allergy Immunol. 2020;31(26):96–101.
   PubMedGoogle Scholar
• Passante M, Napolitano M, Dastoli S, et al. Safety of omalizumab treatment in patients with chronic spontaneous urticaria and COVID-19. Dermatol Ther. 2021;34(6):e15111.
   PubMedGoogle Scholar